Valuation: EUROAPI

Market Cap 93.24M 108M 87.47M 79.67M 150M 10.33B 152M 1.03B 402M 5.17B 405M 397M 17.21B P/E 2026 *
-0.65x
P/E 2027 * -1.86x
Enterprise Value 148M 172M 139M 127M 239M 16.44B 242M 1.63B 640M 8.24B 646M 632M 27.4B EV / Sales 2026 *
0.2x
EV / Sales 2027 * 0.2x
Free-Float
64.75%
Yield 2026 *
-
Yield 2027 * -
1 day-22.52%
Current month-22.52%
1 month-22.52%
3 months-24.52%
6 months-53.75%
Current year-55.51%
1 month 1.17
Extreme 1.17
1.17
Current year 1.17
Extreme 1.17
2.54
1 year 1.17
Extreme 1.17
3.59
3 years 1.17
Extreme 1.17
12.7
5 years 1.17
Extreme 1.17
23.4
10 years 1.17
Extreme 1.17
23.4
Manager TitleAgeSince
Chief Executive Officer - 2024-12-08
Director of Finance/CFO - 2024-10-16
Compliance Officer - 2023-11-26
Director TitleAgeSince
Director/Board Member 62 2022-05-05
Director/Board Member - 2022-05-05
Chairman 57 2024-12-08
Change 5-day change 1-year change 3-year change Capi.($)
-22.52%0.00% - - 108M
+0.70%-3.31%+70.64%+121.54% 1,052B
+0.46%+0.09%+48.68%+50.59% 627B
+0.36%+0.92%+21.15%+66.82% 441B
+0.28%-4.56%+39.10%+38.05% 349B
+0.78%-2.68%+23.13%+37.32% 287B
+0.87%-3.59%-1.52%+7.12% 241B
+0.26%-0.28%+42.18%+57.68% 224B
-0.78%-4.49%-15.86%-54.13% 202B
+0.32%+4.24%+17.55%+81.31% 172B
Average -2.06%-0.77%+27.23%+45.14% 399.46B
Weighted average by Cap. +0.34%-0.63%+39.88%+64.18%

Financials

2026 *2027 *
Net sales 753M 872M 706M 643M 1.21B 83.37B 1.23B 8.28B 3.24B 41.77B 3.27B 3.2B 139B 760M 881M 713M 650M 1.22B 84.21B 1.24B 8.36B 3.28B 42.19B 3.31B 3.23B 140B
Net income -142M -165M -133M -121M -228M -15.74B -231M -1.56B -612M -7.88B -618M -605M -26.23B -50.07M -57.99M -46.97M -42.78M -80.44M -5.54B -81.56M -551M -216M -2.78B -218M -213M -9.24B
Net Debt 55.24M 63.98M 51.82M 47.2M 88.75M 6.12B 89.98M 607M 238M 3.06B 240M 235M 10.2B 61.91M 71.71M 58.08M 52.9M 99.47M 6.86B 101M 681M 267M 3.44B 269M 263M 11.43B
Logo EUROAPI
EUROAPI specializes in the development and manufacture of active pharmaceutical ingredients on behalf of healthcare industries. The company offers vitamin B12, prostaglandins, oligonucleotides, peptides, corticoids and hormones, anti-infectives, opiates (morphine, codeine, thebaine, etc.), analgesics, etc. EUROAPI has 5 production sites located in France (2), Germany, Italy and Hungary.
Employees
2,961
Date Price Change Volume
26-08-12 US$0.000000 - 20
26-08-11 US$0.000000 -100.00% 17
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
SELL
Number of Analysts
4
Last Close Price
0.9760EUR
Average target price
1.150EUR
Spread / Average Target
+17.83%

Quarterly revenue - Rate of surprise